key: cord-0781951-qr32xrni
authors: Han, Yuling; Yang, Liuliu; Kim, Tae Wan; Nair, Manoj S.; Harschnitz, Oliver; Wang, Pengfei; Zhu, Jiajun; Koo, So Yeon; Tang, Xuming; Lacko, Lauretta A.; Chandar, Vasuretha; Bram, Yaron; Zhang, Tuo; Zhang, Wei; He, Feng; Caicedo, James; Huang, Yaoxing; Evans, Todd; van der Valk, Paul; Titulaer, Maarten J.; Spoor, Jochem K. H.; Furler, Robert L.; Canoll, Peter; Goldman, James E.; Przedborski, Serge; Schwartz, Robert E.; Ho, David D.; Studer, Lorenz; Chen, Shuibing
title: SARS-CoV-2 Infection Causes Dopaminergic Neuron Senescence
date: 2021-05-21
journal: Res Sq
DOI: 10.21203/rs.3.rs-513461/v1
sha: f16f048987c38a844c36b2ee8402fb225282cbd2
doc_id: 781951
cord_uid: qr32xrni

COVID-19 patients commonly present with neurological signs of central nervous system (CNS)(1–3) and/or peripheral nervous system dysfunction(4). However, which neural cells are permissive to infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been controversial. Here, we show that midbrain dopamine (DA) neurons derived from human pluripotent stem cells (hPSCs) are selectively permissive to SARS-CoV-2 infection both in vitro and upon transplantation in vivo, and that SARS-CoV-2 infection triggers a DA neuron inflammatory and cellular senescence response. A high-throughput screen in hPSC-derived DA neurons identified several FDA approved drugs, including riluzole, metformin, and imatinib, that can rescue the cellular senescence phenotype and prevent SARS-CoV-2 infection. RNA-seq analysis of human ventral midbrain tissue from COVID-19 patients, using formalin-fixed paraffin-embedded autopsy samples, confirmed the induction of an inflammatory and cellular senescence signature and identified low levels of SARS-CoV-2 transcripts. Our findings demonstrate that hPSC-derived DA neurons can serve as a disease model to study neuronal susceptibility to SARS-CoV-2 and to identify candidate neuroprotective drugs for COVID-19 patients. The susceptibility of hPSC-derived DA neurons to SARS-CoV-2 and the observed inflammatory and senescence transcriptional responses suggest the need for careful, long-term monitoring of neurological problems in COVID-19 patients.

Main Text. 61 Abnormal neurological manifestations are increasingly recognized in patients with COVID-19 62 which most commonly include anosmia, dysgeusia, and headache followed by seizure, stroke, and 63 acute inflammatory polyradiculoneuropathy also known as Guillain-Barre syndrome 5 . 64 Furthermore, an increased risk for additional neurological and psychiatric disorders has been 65 reported in a large retrospective cohort at 6 months post diagnosis 6 . Up-to-now, however, little is 66 known about which neural cell types or neuronal subtypes are permissive to infection by the severe 67 acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Recently, we developed a human 68 pluripotent stem cell (hPSC)-derived organoid/cell-based platform to evaluate the tropism of 69 SARS-CoV-2. Using this platform, we found that hPSC-derived midbrain dopamine (DA) neurons, 70 representing one of the main target of the neurodegenerative process in Parkinson's disease (PD), 71 are permissive to SARS-CoV-2 infection 7 . Conversely, under identical experimental conditions, 72 we found that hPSC-derived cortical neurons are not permissive to SARS-CoV-2 infection 8 , 73 supporting the notion that not all neuronal populations are equally permissive to viral infection. 74 Here, we set out to define how DA neurons respond to SARS-CoV-2 infection and to determine 75 the molecular changes induced by SARS-CoV-2 infection. Fig. 1a) . Expression of ACE2, the SARS-CoV-2 receptor, in Nurr1:GFP + DA neurons was 81 validated by immunostaining (Extended Data Fig. 1b) . The permissiveness to SARS-CoV-2 entry 82 was further confirmed using a vesicular stomatitis ΔG-luciferase virus pseudotyped with the 83 6 SARS-CoV-2 Spike protein incorporated at the surface of the viral particle (SARS-CoV-2-entry 84 virus) 10, 11 . Robust luciferase activity was readily detected in DA neurons infected with this SARS-85 CoV-2-entry virus (Extended Data Fig. 1c) . Immunostaining further validated the expression of 86 luciferase in DA neurons (Extended Data Fig. 1d ).

To generate an in vivo model to study SARS-CoV-2 infection in human DA neurons, hPSC-89 derived DA neurons were transplanted under the anterior chamber of the eye, which allows the 90 convenient observation of the grafted cells (Fig. 1a) . One week after transplantation, 91 immunohistochemistry was performed to validate ACE2 expression on Nurr1:GFP + DA neurons 92 (Fig. 1b) . At 24 hours after intraocular inoculation with SARS-CoV-2-entry virus (1X10 4 PFU), 93 luciferase was mainly detected in Nurr1: GFP + DA neurons as indicated by immunofluorescence 94 staining (Fig. 1c) . This suggests that hPSC-derived DA neurons are permissive to SARS-CoV-2 95 infection when exposed to the virus in vivo. Due to the limitations of BSL-3 animal protocols, this 96 transplantation model was not further applied to test an intranasal infection route.

Next, hPSC-derived DA neurons were infected in vitro with SARS-CoV-2 (USA-WA1/2020, 99 MOI=0.2). At 48 hours post infection (hpi), qRT-PCR analysis using primers targeting 100 subgenomic N transcripts confirmed that significant amounts of viral replication could be detected 101 at the RNA level in infected hPSC-derived DA neurons (Fig. 1d) . Immunostaining for the SARS-102 N protein confirmed robust SARS-CoV-2 infection of DA neurons (Fig. 1e) . Finally, transmission 103 electron microscopy was used to detect the presence of viral particles in SARS-CoV-2 infected 104 hPSC-derived DA neurons (Fig. 1f) . Overall, these in vitro and in vivo experiments confirm that 105 7 human hPSC-derived DA neurons are permissive to SARS-CoV-2 and support productive 106 infection.

107 108 RNA-seq analysis was applied to compare mock-infected or SARS-CoV-2 infected hPSC-derived 109 DA neurons. Robust viral infection was detected in SARS-CoV-2 infected DA neurons (Fig. 1g) . 110 Moreover, plotting these datasets by principal component analysis (PCA, Fig. 1h ) and clustering 111 analysis (Fig. 1i) demonstrated that the infected DA neurons occupied a distinct transcriptional 112 space compared to mock-infected DA neurons. In contrast, no obvious transcriptional changes 113 were observed following SARS-CoV-2 exposure of hPSC-derived cortical neurons. In hPSC-114 derived DA neurons, we next analyzed DA neuron marker expression and found that levels of 115 FOXA2 and NURR1 were decreased in SARS-CoV-2 infected samples (Fig. 1j) . In particular, 116 markers of the A9 DA neuronsthe subtype of ventral midbrain DA neurons most affected in PD 117 such as LMO3, DKK3, and ALDH1A1 12 , were significantly downregulated in SARS-CoV-2 118 infected cells (Fig. 1j) . Quantitative RNA in situ hybridization further confirmed the decrease of 119 A9 markers including LMO3 expression following SARS-CoV-2 infection, indicating an increased 120 vulnerability of human DA neurons expressing A9 subtype specific markers to SARS-CoV-2 121 infection ( Fig. 1k, 1l) . (Fig. 2a, 2b) . Those transcriptional changes were specific to DA neuron cultures and again not 127 8 observed in cortical neuron cultures, in line with our previous work showing a lack of susceptibility 128 of cortical neurons to SARS-CoV-2 7 . In infected DA neurons, inflammation-associated genes were 129 also upregulated in SARS-CoV-2 infected DA neurons (Fig. 2c) . Ingenuity Pathway Analysis 130 highlighted the senescence pathway as the top regulated pathway in SARS-CoV-2 infected DA 131 neurons (Fig. 2d) , a finding further corroborated by the upregulated expression of key genes 132 involved in the senescence pathway (Fig. 2e) . Beta-galactosidase (Beta-Gal), a biomarker of 133 cellular senescence 8 , was also upregulated in SARS-CoV-2 infected hPSC-derived DA neurons 134 (Fig. 2f, 2g) . qRT-PCR analysis was performed for examining the expression of senescence- were analyzed for levels of Beta-Gal. Compounds with a Z score <-2 were defined as primary hit 148 drugs (Fig. 3a) . The hits were further evaluated for potency and cytotoxicity at different 149 concentrations. Three drugs, riluzole (Fig. 3b, 3e) , metformin (Fig. 3c, 3f) , and imatinib 150 9 (EC50=3.25 μM, CC50=17.14 μM, Fig. 3d, 3g) , reduced Beta-Gal activity in a dose-dependent 151 manner without inducing cytotoxicity. Furthermore, wells treated with either 10 μM riluzole, 50 152 μM metformin, or 10 μM imatinib showed a significant decrease in the total number of Beta-Gal + 153 cells as compared to DMSO treatment (Fig. 3h, 3i) . Finally, qRT-PCR analysis showed a decrease 154 of the senescence-pathway associated gene IGFBP7 and an upregulation of LAMIN B1 for each of 155 the three drugs (Fig. 3j) . (Fig. 3k) , a finding further validated by immunostaining using an antibody 162 against the SARS-CoV-2 Nucleocapsid protein (Fig. 3l, 3m) . Interestingly, we identified imatinib 163 previously as an anti-SARS-CoV-2 drug in hPSC-lung organoids 14 . CCL2  CCL20  CCL25  CX3CL1  CXCL14  IL11  IL12A  IL1A  IL1B  IL34  IL5   ADCY1  C3  CCR7  CD81  CNR1  CX3CL1  FCER1G  HMGB2  ICAM1  ITGB1  LRRK2  NOTCH1  NOTCH2  PPARG  PSEN2  SPHK1  SYT11  TTBK1 neurons. a, Primary screening results. X-axis is the compound number. Y axis is the Z-score. Red 282 line is Z-score <-2, which means the luminescent signal is lower than average-2xSTDEV. b-d, 283 Chemical structures of riluzole (b), metformin (c), and imatinib (d). e-g, Efficacy and cytotoxicity CCL2  CCL20  CCL25  CX3CL1  CXCL14  IL11  IL12A  IL1A  IL1B  IL34  IL5   ADCY1  C3  CCR7  CD81  CNR1  CX3CL1  FCER1G  HMGB2  ICAM1  ITGB1  LRRK2  NOTCH1  NOTCH2  PPARG  PSEN2  SPHK1  SYT11  TTBK1 ZP3 Table 3 . 393 Cell infections were performed at the described MOI in DMEM supplemented with 0.3% BSA, For analysis, the salmon index was built using the human transcriptome GRCh38.p13. The index 416 is a structure that salmon uses to quasi-map RNA-seq reads during quantification. Then, the fastq 417 format RNA-seq raw data was quantified with salmon. The quantification results were analyzed 418 using the tximport package to import salmon's transcript-level quantifications and were aggregated 419 to the gene level for gene-level differential expression analysis using the DESeq2 package. In situ hybridization. 422 

Neurologic Manifestations of Hospitalized Patients With Coronavirus 465 Disease

Clinical features of patients infected with

Neurologic Features in Severe SARS-CoV-2 Infection

Guillain-Barre syndrome 471 during SARS-CoV-2 pandemic: A case report and review of recent literature

Lifting the mask on neurological manifestations of COVID-19

6-month neurological 476 and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study 477 using electronic health records

A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2

Tropism and Model Virus Infection in Human Cells and Organoids

Loss of SATB1 Induces p21-Dependent Cellular Senescence in Post-482 mitotic Dopaminergic Neurons

Biphasic Activation of WNT Signaling Facilitates the Derivation of 484

Midbrain Dopamine Neurons from hESCs for Translational Use

Generation of VSV pseudotypes using recombinant DeltaG-VSV for studies 487 on virus entry, identification of entry inhibitors, and immune responses to vaccines

Establishment and validation of a pseudovirus neutralization assay for SARS-490

Molecular Diversity of Midbrain Development in Mouse, Human, and 492 Stem Cells

Insulin-like growth factor binding proteins 4 and 7 released by senescent 494 cells promote premature senescence in mesenchymal stem cells

Identification of SARS-CoV-2 inhibitors using lung and colonic organoids

COVID-19 Neuropathology at Columbia University Irving Medical 499

Human stem cell models to study host-virus interactions in the 501 central nervous system

SARS-CoV-2 Infects the Brain Choroid Plexus and Disrupts the Blood-503

CSF Barrier in Human Brain Organoids

Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids 505

Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium

Neuroinvasion of SARS-CoV-2 in human and mouse brain

The mesolimbic dopamine reward circuit in depression

Metformin and risk of mortality in patients hospitalised with COVID-512 19: a retrospective cohort analysis

Metformin use is associated with a reduced risk of mortality in patients 514 with diabetes hospitalised for COVID-19

A hPSC-based platform to discover gene-environment interactions that 516 impact human beta-cell and dopamine neuron survival

Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 518 spike

Digital expression explorer 2: a repository of 520 uniformly processed RNA sequencing data

Skewer: a fast and accurate adapter trimmer for 522 next-generation sequencing paired-end reads

Kraken: 524 a set of tools for quality control and analysis of high-throughput sequence data

STAR: ultrafast universal RNA-seq aligner

deepTools2: a next generation web server for deep-sequencing data 529 analysis

Adherent cells plated in a glass-bottom plate are fixed and permeabilized and stained for a protein 423 of interest (TH; tyrosine hydroxylase) in order to locate RNA puncta signals within a mature DA 424 neuron. Following protein detection, a fluorescent in situ hybridization (FISH) and branched DNA 425 amplification technology is used to amplify the signal detection of an RNA transcript. In the first 426 step, a gene-specific oligonucleotide target probe binds to the target RNA sequence. Signal 427 amplification is then achieved through a series of sequential hybridization steps. After two 428 sequential amplifying steps, a fluorescent dye is introduced to hybridize to their corresponding 429 amplifier molecules. RNA signals in dots are visualized using confocal microscopy with 63X oil 430 lenses. All the images in z-stacks were projected and obtained using Imaris software. Projected 431 images were analyzed for quantification.